TY  - CHAP
M1  - Book, Section
TI  - Chronic Stable Angina MTM Data Set
A1  - Anderson, Shawn D.
A1  - Pardo, Kristyn M.
A2  - Whalen, Karen
A2  - Hardin, Heather C.
PY  - 2018
T2  - Medication Therapy Management: A Comprehensive Approach, 2e
AB  - KEY  POINTSStable  ischemic  heart  disease  (SIHD)  is  caused  by  atherosclerotic  plaque  buildup  in  the  coronary  arteries.Angina  results  when  the  heart’s  demand  for  oxygen  exceeds  the  available  supply.Stable  angina  is  reproducible  and  relieved  by  rest  or  nitroglycerin.  An  increase  in  angina  frequency,  severity,  or  duration  characterizes  it  as  “unstable.”  A  patient  with  unstable  angina  should  be  referred  for  medical  evaluation.Acute  angina  attacks  that  do  not  resolve  with  rest  may  require  the  use  of  nitroglycerin.  Medication  therapy  management  (MTM)  providers  should  counsel  on  proper  use  of  nitroglycerin,  including  when  to  call  911.Management  of  chronic  stable  angina  aims  to  reduce  the  frequency  of  angina  attacks.  β-Blockers,  calcium  channel  blockers,  and  long-acting  nitrates  are  common  treatments.MTM  providers  should  stress  the  importance  of  adherence  to  medications  for  chronic  stable  angina,  and  counsel  on  appropriate  use  of  medications  to  maximize  the  therapeutic  effect,  eg,  the  importance  of  a  nitrate-free  interval  for  patients  on  long-acting  nitrates.  
SN  - 
PB  - McGraw-Hill Education
CY  - New York, NY
Y2  - 2024/04/24
UR  - accesspharmacy.mhmedical.com/content.aspx?aid=1150199260
ER  -